Leveraging Early Imaging Data to Build Effective Theranostic Strategies Across Novel Targets

• Translating early imaging molecules into theranostic pairs by optimising binder and molecular properties for therapeutic development
• Comparing learnings across Bicycle® Radio Conjugate programmes targeting MT1 and EphA2 to inform development decisions across different tumour targets
• Demonstrating how emerging MT1 imaging data, including the detection of brain metastases, can strengthen patient-selection and clinical translation strategies

Speakers:

Jitka Riedl

Associate Principal Scientist, Project Leader

Bicycle Therapeutics